TotalMarketCap

Sarepta Therapeutics

SRPTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.850 B

$17.51 -7.79%

Close of 6 Nov 2026

As of 6 Nov 2026, Sarepta Therapeutics (SRPT) has a market capitalization of $1.85B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.20B

#1085 by revenue

Earnings

-$713.4M

Loss-making

Shares outstanding

107,235,848

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #97First Tracks BiotherapeuticsTRAX$1.92B
  2. #98Harmony BiosciencesHRMY$1.91B
  3. #99Sarepta TherapeuticsSRPT$1.85B
  4. #100Trevi TherapeuticsTRVI$1.84B
  5. #101Maravai LifesciencesMRVI$1.81B

What if Sarepta Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$267,326.23

Per share 15,267× higher

Bitcoin $1.53T

$14,464.56

Per share 826× higher

Apple $5.02T

$47,485.79

Per share 2,712× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Sarepta Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.